Decheng Capital
About Decheng Capital
Decheng Capital is a venture capital firm that provides capital to early and growth stage life science companies.
Investment focus
Stages
Sectors
Portfolio (6 in our database)
GenapsysTransform the human condition by building a scalable, affordable genomic sequencing ecosystem that will support research and diagnosticsSeries D · $319M raisedACELYRINACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.Series B · $258M raisedNeurelisNeurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.Series D · $206M raisedShape TherapeuticsA biotechnology company developing RNA technologies to shape the future of gene therapySeries B · $148M raisedEncodiaEncodia is a biotech company that develops the next generation of protein analysis tools.Series C · $75M raisedLevitasBioLevitasBio is advancing science and human health by providing researchers with a new and powerful method of cellular analysis.Series B · $26M raised